Cardiology · 2010 · 69 citations · 31 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyRabbit MedicineCardiac BiomarkersCardiac PharmacotherapyCardiac PhysiologyCardiovascular DiseaseCardiovascular PathophysiologyCardiovascular PharmacologyCardiac Fibrosis ModulationCardiac Systolic FunctionDiastolic Function EvaluationHeart RateIvabradine TherapyLeft Ventricular Systolic FunctionMyocardial Performance IndexVentricular Diastolic Function
OBJECTIVES: To determine if heart rate (HR) reduction with ivabradine (IVA), a selective inhibitor of the pacemaker I(f) current, prevents cardiac dysfunction associated with dyslipidemia. METHODS: New Zealand White rabbits received either a standard diet, a 0.5% cholesterol-enriched diet only (CD), or a 0.5% CD with IVA (17 mg/kg/day) for 12 weeks. HR, left ventricular (LV) systolic function, diastolic function and LV regional myocardial performance index (MPI) were studied using echocardiography. Histological analysis included cardiac interstitial fibrosis and collagen type I fibers. Plasma levels of angiotensin II and aldosterone were quantified by immunoassays. RESULTS: IVA reduced HR by approximately 11%. IVA improved MPI and attenuated LV diastolic dysfunction (DD) (92% mild and 8% moderate DD with IVA vs. 54% mild and 46% moderate DD in CD group). IVA also reduced atrial fibrosis (p = 0.027), ventricular fibrosis (p = 0.0002) and ventricular collagen type I (p = 0.0042). IVA decreased plasma angiotensin II levels (p = 0.042), and both angiotensin II and aldosterone levels were correlated with HR (p = 0.038 and 0.008). CONCLUSION: Selective HR reduction with IVA reduces DD and cardiac fibrosis in hypercholesterolemic rabbits. These beneficial effects of IVA support testing pure HR reduction in patients with diastolic heart failure.
31
Effects of Torcetrapib in Patients at High Risk for Coronary Events
Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text
Medicine, Cardiology, Pharmacology +14
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Danshi Li, Samir Fareh, Tack Ki Leung et al. · Circulation · 1999 · 1.3K citations
Heart rate and cardiovascular mortality: The Framingham study
William B. Kannel, Craig Kannel, Ralph S. Paffenbarger et al. · American Heart Journal · 1987 · 1.3K citations
Kim Fox, Ian Ford, Philippe Gabríel Steg et al. · The Lancet · 2008 · 788 citations